All Studies Meta Analysis Recent:

Zinc use is associated with improved outcomes in COVID-19: results from the CRUSH-COVID registry

Mayberry et al., Critical Care Medicine, doi:10.1097/01.ccm.0000807104.82650.d6

Dec 2021

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Download Image

Zinc for COVID-19

2nd treatment shown to reduce risk in July 2020

^*, now with p = 0.00000064 from 45 studies, recognized in 17 countries.

Lower risk for mortality, ventilation, hospitalization, progression, recovery, and viral clearance.

No treatment is 100% effective. Protocols combine treatments. ^* >10% efficacy, ≥3 studies.

4,500+ studies for 81 treatments. c19early.org

Retrospective 2,028 COVID patients in the USA, showing significantly lower mortality, ventilation, ICU admission, and progression to ARDS with zinc use, defined as at least one dose from one week prior to admission to 48 hours after admission.

Important missing comments or errors? Let us know.

risk of death, 53.5% lower, OR 0.47, p < 0.001, treatment 938, control 1,090, adjusted per study, multivariable, RR approximated with OR.

risk of mechanical ventilation, 64.2% lower, OR 0.36, p < 0.001, treatment 938, control 1,090, adjusted per study, multivariable, RR approximated with OR.

risk of ICU admission, 60.0% lower, OR 0.40, p < 0.001, treatment 938, control 1,090, adjusted per study, multivariable, RR approximated with OR.

death/ventilation/ICU, 57.8% lower, OR 0.42, p < 0.001, treatment 938, control 1,090, adjusted per study, multivariable, primary outcome, RR approximated with OR.

progression to ARDS, 85.4% lower, OR 0.15, p < 0.001, treatment 938, control 1,090, adjusted per study, multivariable, RR approximated with OR.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Mayberry et al., 16 Dec 2021, retrospective, USA, peer-reviewed, 14 authors, study period March 2020 - April 2021.

This Paper Zinc All

{ 'indexed': { 'date-parts': [[2021, 12, 22]], 'date-time': '2021-12-22T06:50:45Z', 'timestamp': 1640155845018}, 'reference-count': 0, 'publisher': 'Ovid Technologies (Wolters Kluwer Health)', 'issue': '1', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': [], 'published-print': {'date-parts': [[2022, 1]]}, 'DOI': '10.1097/01.ccm.0000807104.82650.d6', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 12, 16]], 'date-time': '2021-12-16T20:06:47Z', 'timestamp': 1639685207000}, 'page': '81-81', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': [ '195: ZINC USE IS ASSOCIATED WITH IMPROVED OUTCOMES IN COVID-19: RESULTS FROM THE CRUSH-COVID ' 'REGISTRY'], 'prefix': '10.1097', 'volume': '50', 'author': [ {'given': 'Miles', 'family': 'Mayberry', 'sequence': 'first', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Chow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Park', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lynnette', 'family': 'Harris', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amit', 'family': 'Saha', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Levine', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathan', 'family': 'Smischney', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick', 'family': 'Wieruszewski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nikhil', 'family': 'Meena', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Yamane', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amanda', 'family': 'Jackson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shravan', 'family': 'Kethireddy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Wiepking', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ashish', 'family': 'Khanna', 'sequence': 'additional', 'affiliation': []}], 'member': '276', 'published-online': {'date-parts': [[2021, 12, 16]]}, 'container-title': ['Critical Care Medicine'], 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://journals.lww.com/10.1097/01.ccm.0000807104.82650.d6', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 12, 21]], 'date-time': '2021-12-21T12:16:45Z', 'timestamp': 1640089005000}, 'score': 1, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 12, 16]]}, 'references-count': 0, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2022]]}}, 'URL': 'http://dx.doi.org/10.1097/01.ccm.0000807104.82650.d6', 'relation': {}, 'ISSN': ['0090-3493'], 'issn-type': [{'value': '0090-3493', 'type': 'print'}], 'subject': ['Critical Care and Intensive Care Medicine'], 'published': {'date-parts': [[2021, 12, 16]]}}

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0